Randomized Trial of Edoxaban Versus Enoxaparin-Warfarin to Treat Atrial Fibrillation

被引：0
|
作者：
不详
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2017年 / 101卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
  • [1] Anticoagulation Control in Warfarin-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the Edoxaban Versus Enoxaparin-Warfarin in Patients Undergoing Cardioversion of Atrial Fibrillation Trial)
    Lip, Gregory Y. H.
    Al-Saady, Naab
    Jin, James
    Sun, Ming
    Melino, Michael
    Winters, Shannon M.
    Zamoryakhin, Dmitry
    Goette, Andreas
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (05): : 792 - 796
  • [2] Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial
    Goette, Andreas
    Merino, Jose L.
    Ezekowitz, Michael D.
    Zamoryakhin, Dmitry
    Melino, Michael
    Jin, James
    Mercuri, Michele F.
    Grosso, Michael A.
    Fernandez, Victor
    Al-Saady, Naab
    Pelekh, Natalya
    Zenin, Sergey
    Kushnir, Mykola
    Spinar, Jindrich
    Batushkin, Valeriy
    Lip, Gregory Y. H.
    Weitz, Jeffrey
    Freemantle, Nicholas
    Klein, Helmut
    Buller, Harry
    Segers, Annelise
    Roos, Yvo
    Slagboom, Ton
    Thijs, Vincent
    van Mechelen, Rob
    Larrey, Dominique
    Laleman, Wim
    Huber, Kurt
    Heidbuchel, Hein
    Goudev, Assen
    Kautzner, Josef
    Rasmussen, Lars
    Cohen, Ariel
    Le Heuzey, Jean-Yves
    Glikson, Michael
    Themistoclakis, Sakis
    De Caterina, Raffaele
    Banach, Maciej
    Dan, Gheorghe-Andrei
    Ruda, Mikhail
    Lundqvist, Carina Blomstrom
    Sychov, Oleg
    Ellenbogen, Kenneth
    Ezekowitz, Michael
    Gwechenberger, Marianne
    Huber, Kurt
    Purerfellner, Helmut
    Roithinger, Franz
    Scherr, Daniel
    Stuhlinger, Markus
    [J]. LANCET, 2016, 388 (10055): : 1995 - 2003
  • [3] Edoxaban versus Warfarin in Patients with Atrial Fibrillation
    Giugliano, Robert P.
    Ruff, Christian T.
    Braunwald, Eugene
    Murphy, Sabina A.
    Wiviott, Stephen D.
    Halperin, Jonathan L.
    Waldo, Albert L.
    Ezekowitz, Michael D.
    Weitz, Jeffrey I.
    Spinar, Jindrich
    Ruzyllo, Witold
    Ruda, Mikhail
    Koretsune, Yukihiro
    Betcher, Joshua
    Shi, Minggao
    Grip, Laura T.
    Patel, Shirali P.
    Patel, Indravadan
    Hanyok, James J.
    Mercuri, Michele
    Vogelmann, O.
    Gonzalez, C.
    Ahuad Guerrero, R.
    Rodriguez, M.
    Albisu, J.
    Rosales, E.
    Allall, O.
    Reguero, M.
    Alvarez, C.
    Garcia, M.
    Ameriso, S.
    Ameriso, P.
    Amuchastegui, M.
    Caceres, M.
    Beloscar, J.
    Petrucci, J.
    Berli, M.
    Budassi, N.
    Valle, M.
    Bustamante Labarta, G.
    Saravia, M.
    Caccavo, A.
    Fracaro, V.
    Cartasegna, L.
    Novas, V.
    Caruso, O.
    Saa Zarandon, R.
    Colombo, H.
    Morandini, M.
    Cuello, J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (22): : 2093 - 2104
  • [4] Edoxaban versus Warfarin in patients with atrial fibrillation
    Meras Colunga, P.
    [J]. REVISTA CLINICA ESPANOLA, 2014, 214 (06): : 346 - 346
  • [5] Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial (vol 388, pg 1995, 2016)
    Goette, A.
    Merino, J. L.
    Ezekowitz, M. D.
    [J]. LANCET, 2016, 388 (10055): : 1984 - 1984
  • [6] Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease
    Qamar, Arman
    Antman, Elliott M.
    Ruff, Christian T.
    Nordio, Francesco
    Murphy, Sabina A.
    Grip, Laura T.
    Greenberger, Norton J.
    Yin, Ophelia Q. P.
    Choi, Youngsook
    Lanz, Hans J.
    Mercuri, Michele F.
    Braunwald, Eugene
    Giugliano, Robert P.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (02) : 179 - 189
  • [7] Edoxaban vs warfarin in vitamin K antagonist experienced and naive patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial
    Lip, G. Y. H.
    Al-Saady, N.
    Hjortshoj, S. P.
    Goudev, A.
    Huber, K.
    Cohen, A. -A.
    Jin, J.
    Merino, M.
    Winters, S. M.
    Goette, A.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 414 - 414
  • [8] EDOXABAN VERSUS WARFARIN IN ATRIAL FIBRILLATION ABLATION: FIRST EXPERIENCE FROM THE ENGAGE AF TIMI 48 TRIAL
    Steffel, Jan
    Ruff, Christian
    Hammershock, Rose
    Murphy, Sabina
    Lanz, Hans
    Mercuri, Michele
    Antman, Elliott
    Braunwald, Eugene
    Giugliano, Robert
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 366 - 366
  • [9] Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation The ENGAGE AF-TIMI 48 Trial
    Corbalan, Ramon
    Carlos Nicolau, Jose
    Lopez-Sendon, Jose
    Garcia-Castillo, Armando
    Botero, Rodrigo
    Sotomora, Gustavo
    Horna, Manuel
    Ruff, Christian T.
    Hamershock, Rose A.
    Grip, Laura T.
    Antman, Elliott M.
    Braunwald, Eugene
    Giugliano, Robert P.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : 1466 - 1475
  • [10] Edoxaban versus warfarin in vitamin K antagonist experienced and naive patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial
    Koziel, Monika
    Al-Saady, Naab
    Hjortshoj, Soren P.
    Goudev, Assen
    Huber, Kurt
    Cohen, Ariel
    Jin, James
    Melino, Michael
    Winters, Shannon M.
    Goette, Andreas
    Lip, Gregory Y. H.
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2020, 109 (08) : 1018 - 1024
12345